Last updated on 9 May 2024
Owner Info
Alexion Pharmaceuticals, Inc.
121 Seaport Boulevard
Boston MA 02210, UNITED STATES OF AMERICA
Serial Number
2313716 filed on 10 Oct 2022
Correspondent
Dennemeyer & Associates S.A.
55 rue des Bruyères,
L-1274 Howald,
LUXEMBOURG
2313716
10 Oct 2022
10 Oct 2032
WORD
22 Jul 2022
US
Status Date | Action Taken |
---|---|
9th May 2024 | Amendment to International Registration Contact Requested |
3rd Mar 2023 | International Registration in Australia Protected correspondence sent |
2th Mar 2023 | IP Right Registration Published |
2th Mar 2023 | Status change to Registered/Protected |
23rd Dec 2022 | Application Accepted correspondence sent |
23rd Dec 2022 | IP Right has been Examined |
23rd Dec 2022 | IP Right Acceptance Published |
16th Nov 2022 | Status change to Accepted |
15th Nov 2022 | Awaiting examination |
15th Nov 2022 | Examination expedited |